Jump to main content

Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats

Icons representing 記事
The cover of this title could differ from library to library. Link to Help Page

Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats

Persistent ID (NDL)
info:ndljp/pid/11851738
Material type
記事
Author
Shohei Yamadaほか
Publisher
Springer Nature
Publication date
2021-01-06
Material Format
Digital
Journal name
Clinical and experimental nephrology : official publication of the Japanese Society of Nephrology 25(4)
Publication Page
-
View Details

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある電子書籍・電子雑誌の提供元Webサイトなどから、本文を自由に閲覧できる場合があります。

Detailed bibliographic record

Summary, etc.:

コレクション : 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他(Provided by: CiNii Research)

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • CiNii Research

    Search Service
    Digital
    You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
記事
Author/Editor
Shohei Yamada
Jun Tanabe
Yuji Ogura
Publication, Distribution, etc.
Publication Date
2021-01-06
Publication Date (W3CDTF)
2021-01-06
Periodical title
Clinical and experimental nephrology : official publication of the Japanese Society of Nephrology
No. or year of volume/issue
25(4)
Volume
25(4)
ISSN (Periodical Title)
1437-7799
ISSN-L (Periodical Title)
1437-7799
Text Language Code
eng
Persistent ID (NDL)
info:ndljp/pid/11851738
Collection (Materials For Handicapped People:1)
Collection (particular)
国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
Acquisition Basis
オンライン資料収集制度
Date Accepted (W3CDTF)
2021-10-28T02:09:55+09:00
Date Captured (W3CDTF)
2021-09-30
Format (IMT)
application/pdf
Access Restrictions
国立国会図書館内限定公開
Service for the Digitized Contents Transmission Service
図書館・個人送信対象外
Availability of remote photoduplication service
Periodical Title (Persistent ID (NDL))
info:ndljp/pid/11851736
Data Provider (Database)
国立国会図書館 : 国立国会図書館デジタルコレクション

Digital

Summary, etc.
コレクション : 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
Access Restrictions
インターネット公開
Is Referenced By
Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats
Endurance Exercise Training-Attenuated Diabetic Kidney Disease with Muscle Weakness in Spontaneously Diabetic Torii Fatty Rats
Effects of glucagon-like peptide-1 receptor agonists on spermatogenesis-related gene expression in mouse testis and testis-derived cell lines
References
The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
High-Fat Diet–Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Liraglutide Improves Renal Endothelial Function in Obese Zucker Rats on a High-Salt Diet
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD
Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy
Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy
Liraglutide ameliorates renal injury in streptozotocin-induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor-κB pathway
The Possibility of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker of Renal Hypoxia in Spontaneously Diabetic Torii Fatty Rats
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes
Diabetic eNOS knockout mice develop distinct macro- and microvascular complications
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Liraglutide promotes autophagy by regulating the AMPK/mTOR pathway in a rat remnant kidney model of chronic renal failure
Long-Term Treatment of Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Diabetic Nephropathy through Improving Metabolic Anomalies in db/db Mice
GLP-1-induced renal vasodilation in rodents depends exclusively on the known GLP-1 receptor and is lost in prehypertensive rats
Renal hemodynamic effects of glucagon-like peptide-1 agonist are mediated by nitric oxide but not prostaglandin
Glucagon-like peptide-1 receptors in the kidney: impact on renal autoregulation
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
Diabetes-Associated Complications in Spontaneously Diabetic Torii Fatty Rats
Data Provider (Database)
国立情報学研究所 : CiNii Research
Bibliographic ID (NDL)
11851738